Financial statements Neurodio
Balance sheet data of NEURODIO
Year
|
2021
|
2022
|
2023
|
---|---|---|---|
Total assets | 86 195,51 | 196 206,51 | 295 582,39 |
A. Fixed assets | 5 876,70 | 1 488,30 | 0,00 |
B. Current assets | 80 318,81 | 194 718,21 | 295 582,39 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
Total liabilities | 4 273,00 | 196 206,51 | 295 582,39 |
A. Equity | -3 518,67 | 92 532,12 | 149 558,31 |
B. Liabilities and provisions for liabilities | 89 714,18 | 103 674,39 | 146 024,08 |
I. Long-term liabilities | 56 850,00 | 0,00 | 65 260,00 |
II. Short-term liabilities | 32 927,85 | 103 674,39 | 80 764,08 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.